Cytokinetics, Incorporated
CYTK
$74.13
$0.680.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -198.76M | -206.03M | -183.03M | -306.18M | -134.37M |
| Total Depreciation and Amortization | 3.63M | 3.38M | 2.86M | 2.68M | 2.29M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 60.53M | 57.42M | 39.36M | 173.46M | 54.96M |
| Change in Net Operating Assets | -25.24M | -219.00K | -1.85M | 22.53M | -51.11M |
| Cash from Operations | -159.84M | -145.46M | -142.65M | -107.51M | -128.24M |
| Capital Expenditure | -4.33M | -5.93M | -5.64M | -9.35M | -4.15M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -502.66M | 151.42M | -65.55M | -61.63M | 57.03M |
| Cash from Investing | -507.00M | 145.49M | -71.19M | -70.98M | 52.88M |
| Total Debt Issued | -- | -- | 0.00 | 729.46M | -- |
| Total Debt Repaid | -3.81M | -2.74M | -2.72M | -405.21M | -2.70M |
| Issuance of Common Stock | 798.15M | 11.35M | 14.65M | 6.94M | 6.75M |
| Repurchase of Common Stock | -1.49M | -841.00K | -1.22M | -720.00K | -514.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00M | 0.00 | 75.00M |
| Cash from Financing | 792.86M | 7.77M | 110.71M | 330.47M | 78.53M |
| Foreign Exchange rate Adjustments | -595.00K | -483.00K | 191.00K | 46.00K | -682.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 125.42M | 7.32M | -102.95M | 152.03M | 2.50M |